Point-of-Care Diagnostics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Point of Care Diagnostics Market
The Point of Care Diagnostics Market Size was valued at USD 77.73 billion in 2023, and the Market is now projected to grow from USD 82.16 billion in 2024 to USD 128.11 billion by 2032, exhibiting a CAGR of 5.7% during the forecast period of 2024-2032.
Another contributing factor was the increased authorization given to authorities like the FDA to grant emergency use to new POC diagnostic tests to help accelerate its emergence and implementation. The growing demand for faster and more effective diagnosis accelerated innovative developments in tests, requiring juridical new assays, portable devices, and sophisticated biosensors. This demand led to higher adoption of POC diagnostic tests for the differential identification of the virus since testing became a key tool of control and management of the coronavirus, impeding the rise of Point of Care Diagnostics Market Growth.
The demand for Point of Care Diagnostics has risen due to the Increasing Prevalence of Chronic and Infectious Diseases, resulting in the expansion of Point of Care Diagnostics Market share globally. Growth in the current society of diabetes, cardiovascular diseases, as well as other respiratory diseases are some of the ailments that require close monitoring, and this is where POC diagnostics prove valuable.
Molecular diagnostics, biosensors as well as microfluidic systems are recognized as the trends in the field of POC testing because of the implementation of the modern technologies. They also enhance the efficiency, specificity, and generality of diagnostic assays in a way that the traditional methods failed to achieve. For instance, multiplex PCR-based tests and next-generation sequencing are progressively popularizing in POC diagnostics. Molecular testing is now more sensitive and specific and has seen significant growth in fields like PCR and NGS. For this reason, care can be delivered faster because these technologies are highly sensitive and specific: these devices can identify pathogens, mutations, and other biomarkers that signify disease immediately onsite.
Comprehensive Analysis of Point of Care Diagnostics Market
The Point of Care Diagnostics Market is rising at an exponential rate due to its market segmentation. This market expansion effectively provides a detailed regional assessment considering the dominant supply and demand forces that impact the Healthcare Industry. These Segmentations are methodically segregated by Product by Sample and by End-User. The Product includes Blood Glucose Monitoring, Infectious Disease Testing, Cardiometabolic Disease Testing, Pregnancy & Fertility Testing, Hematology Testing, and others. The Sample includes Blood, Nasal and Oropharyngeal Swabs, Urine, and others. However, The End-User includes Hospital Bedside, Physician’s Office Lab, Urgent Care & Retail Clinics, and Home & Self Testing.
The North American region leads the Point of Care Diagnostics Market by benefitting a market size of USD 10.92 billion in 2023 due to the increased prevalence of acute conditions including diabetes, cardiovascular diseases, and cancer, which have in turn increased the need for POC diagnostic tests. These are conditions that need constant tracking and addressing, which is well work done by POC devices.
The top players in the market play a crucial role in the Healthcare Industry assuring industrial prospectus growth and setting market standards. These players include F.Hoffman-La Roche Ltd. (Switzerland), Abbott (US), EKF Diagnostics Holdings plc (UK), Cardinal Health, Inc. (US), Thermo Fisher Scientific Inc. (US), Quest Diagnostics Incorporated (US), BD (US), bioMerieux SA (France), QuidelOrtho Corporation (US), Bio-Rad Laboratories Inc. (US). These market players provide a level playing competitive landscape.
In October 2023, EKF Diagnostics inaugurated its new life sciences manufacturing and production plant in the United States of America. Its anglice is annexed to meet the rising demand of its expanding customer base.
Segmentation Table
ATTRIBUTE DETAILS
Study Period 2019-2032
Base Year 2023
Estimated Year 2024
Forecast Period 2024-2032
Growth Rate CAGR of 6.2% from 2024-2032
Historical Period 2019-2022
Unit Value (USD Billion)
Segmentation By Product
Blood Glucose Monitoring
Infectious Disease Testing
Cardiometabolic Disease Testing
Pregnancy & Fertility Testing
Hematology Testing
Others
By Sample
Blood
Nasal and Oropharyngeal Swabs
Urine
Others
By End-User
Hospital Bedside
Physician’s Office Lab
Urgent Care & Retail Clinics
Home & Self testing
By Region
North America (By Product, Sample, End-User, and Country)
- U.S. (By Product)
- Canada (By Product)
Europe (By Product, Sample, End-User, and Country/Sub-region)
- U.K. (By Product)
- Germany (By Product)
- France (By Product)
- Italy (By Product)
- Spain (By Product)
- Scandinavia (By Product)
- Rest of Europe (By Product)
Asia Pacific (By Product, Sample, End-User, and Country/Sub-region)
- China (By Product)
- Japan (By Product)
- India (By Product)
- Australia (By Product)
- Southeast Asia (By Product)
- Rest of Asia Pacific (By Product)
Latin America (By Product, Sample, End-User, and Country/Sub-region)
- Brazil (By Product)
- Mexico (By Product)
- Rest of Latin America (By Product)
Middle East & Africa (By Product, Sample, End-User, and Country/Sub-region)
- GCC (By Product)
- South Africa (By Product)
Rest of the Middle East & Africa (By Product)
Please Note: It will take 2-3 business days to complete the report upon order confirmation.
- 1. Introduction
- 1.1. Market Scope
- 1.2. Market Segmentation
- 1.3. Market Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 4. Key Insights
- 4.1. Prevalence of Key Disease Indications– For Key Country/Region
- 4.2. Technological Advancements in the Point of Care Diagnostics
- 4.3. New Product Launches, Key Players
- 4.4. Overview of Regulatory Scenario, Key Countries/ Region
- 4.5. Key Industry Developments - Mergers, Acquisitions, and Partnerships
- 4.6. COVID-19 Impact on the Point of Care Diagnostics Market
- 5. Global Point of Care Diagnostics Market Analysis, Insights and Forecast, 2019-2032
- 5.1. Market Analysis, Insights and Forecast – By Product
- 5.1.1. Blood Glucose Monitoring
- 5.1.2. Infectious Diseases
- 5.1.3. Cardiometabolic Diseases
- 5.1.4. Pregnancy & Fertility Testing
- 5.1.5. Hematology Testing
- 5.1.6. Others
- 5.2. Market Analysis, Insights and Forecast – By Sample
- 5.2.1. Blood
- 5.2.2. Nasal and Oropharyngeal Swabs
- 5.2.3. Urine
- 5.2.4. Others
- 5.3. Market Analysis, Insights and Forecast – By End User
- 5.3.1. Hospital Bedside
- 5.3.2. Physician’s Office Lab
- 5.3.3. Urgent Care & Retail Clinics
- 5.3.4. Home & Self-testing
- 5.4. Market Analysis, Insights and Forecast – By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
- 6. North America Point of Care Diagnostics Market Analysis, Insights and Forecast, 2019-2032
- 6.1. Market Analysis, Insights and Forecast – By Product
- 6.1.1. Blood Glucose Monitoring
- 6.1.2. Infectious Diseases
- 6.1.3. Cardiometabolic Diseases
- 6.1.4. Pregnancy & Fertility Testing
- 6.1.5. Hematology Testing
- 6.1.6. Others
- 6.2. Market Analysis, Insights and Forecast – By Sample
- 6.2.1. Blood
- 6.2.2. Nasal and Oropharyngeal Swabs
- 6.2.3. Urine
- 6.2.4. Others
- 6.3. Market Analysis, Insights and Forecast – By End User
- 6.3.1. Hospital Bedside
- 6.3.2. Physician’s Office Lab
- 6.3.3. Urgent Care & Retail Clinics
- 6.3.4. Home & Self-testing
- 6.4. Market Analysis, Insights and Forecast – By Country
- 6.4.1. U.S
- 6.4.1.1. By Product
- 6.4.2. Canada
- 6.4.2.1. By Product
- 7. Europe Point of Care Diagnostics Market Analysis, Insights and Forecast, 2019-2032
- 7.1. Market Analysis, Insights and Forecast – By Product
- 7.1.1. Blood Glucose Monitoring
- 7.1.2. Infectious Diseases
- 7.1.3. Cardiometabolic Diseases
- 7.1.4. Pregnancy & Fertility Testing
- 7.1.5. Hematology Testing
- 7.1.6. Others
- 7.2. Market Analysis, Insights and Forecast – By Sample
- 7.2.1. Blood
- 7.2.2. Nasal and Oropharyngeal Swabs
- 7.2.3. Urine
- 7.2.4. Others
- 7.3. Market Analysis, Insights and Forecast – By End User
- 7.3.1. Hospital Bedside
- 7.3.2. Physician’s Office Lab
- 7.3.3. Urgent Care & Retail Clinics
- 7.3.4. Home & Self-testing
- 7.4. Market Analysis, Insights and Forecast – By Country/Sub-region
- 7.4.1. U.K.
- 7.4.1.1. By Product
- 7.4.2. Germany
- 7.4.2.1. By Product
- 7.4.3. France
- 7.4.3.1. By Product
- 7.4.4. Spain
- 7.4.4.1. By Product
- 7.4.5. Italy
- 7.4.5.1. By Product
- 7.4.6. Scandinavia
- 7.4.6.1. By Product
- 7.4.7. Rest of Europe
- 7.4.7.1. By Product
- 8. Asia Pacific Point of Care Diagnostics Market Analysis, Insights and Forecast, 2019-2032
- 8.1. Market Analysis, Insights and Forecast – By Product
- 8.1.1. Blood Glucose Monitoring
- 8.1.2. Infectious Diseases
- 8.1.3. Cardiometabolic Diseases
- 8.1.4. Pregnancy & Fertility Testing
- 8.1.5. Hematology Testing
- 8.1.6. Others
- 8.2. Market Analysis, Insights and Forecast – By Sample
- 8.2.1. Blood
- 8.2.2. Nasal and Oropharyngeal Swabs
- 8.2.3. Urine
- 8.2.4. Others
- 8.3. Market Analysis, Insights and Forecast – By End User
- 8.3.1. Hospital Bedside
- 8.3.2. Physician’s Office Lab
- 8.3.3. Urgent Care & Retail Clinics
- 8.3.4. Home & Self-testing
- 8.4. Market Analysis, Insights and Forecast – By Country/Sub-region
- 8.4.1. Japan
- 8.4.1.1. By Product
- 8.4.2. China
- 8.4.2.1. By Product
- 8.4.3. India
- 8.4.3.1. By Product
- 8.4.4. Australia
- 8.4.4.1. By Product
- 8.4.5. Southeast Asia
- 8.4.5.1. By Product
- 8.4.6. Rest of Asia Pacific
- 8.4.6.1. By Product
- 9. Latin America Point of Care Diagnostics Market Analysis, Insights and Forecast, 2019-2032
- 9.1. Market Analysis, Insights and Forecast – By Product
- 9.1.1. Blood Glucose Monitoring
- 9.1.2. Infectious Diseases
- 9.1.3. Cardiometabolic Diseases
- 9.1.4. Pregnancy & Fertility Testing
- 9.1.5. Hematology Testing
- 9.1.6. Others
- 9.2. Market Analysis, Insights and Forecast – By Sample
- 9.2.1. Blood
- 9.2.2. Nasal and Oropharyngeal Swabs
- 9.2.3. Urine
- 9.2.4. Others
- 9.3. Market Analysis, Insights and Forecast – By End User
- 9.3.1. Hospital Bedside
- 9.3.2. Physician’s Office Lab
- 9.3.3. Urgent Care & Retail Clinics
- 9.3.4. Home & Self-testing
- 9.4. Market Analysis, Insights and Forecast – By Country/Sub-region
- 9.4.1. Brazil
- 9.4.1.1. By Product
- 9.4.2. Mexico
- 9.4.2.1. By Product
- 9.4.3. Rest of Latin America
- 9.4.3.1. By Product
- 10. Middle East & Africa Point of Care Diagnostics Market Analysis, Insights and Forecast, 2019-2032
- 10.1. Market Analysis, Insights and Forecast – By Product
- 10.1.1. Blood Glucose Monitoring
- 10.1.2. Infectious Diseases
- 10.1.3. Cardiometabolic Diseases
- 10.1.4. Pregnancy & Fertility Testing
- 10.1.5. Hematology Testing
- 10.1.6. Others
- 10.2. Market Analysis, Insights and Forecast – By Sample
- 10.2.1. Blood
- 10.2.2. Nasal and Oropharyngeal Swabs
- 10.2.3. Urine
- 10.2.4. Others
- 10.3. Market Analysis, Insights and Forecast – By End User
- 10.3.1. Hospital Bedside
- 10.3.2. Physician’s Office Lab
- 10.3.3. Urgent Care & Retail Clinics
- 10.3.4. Home & Self-testing
- 10.4. Market Analysis, Insights and Forecast – By Country/Sub-region
- 10.4.1. GCC
- 10.4.1.1. By Product
- 10.4.2. South Africa
- 10.4.2.1. By Product
- 10.4.3. Rest of Middle East & Africa
- 10.4.3.1. By Product
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis (2023)
- 11.2. Company Profiles
- 11.2.1. F. Hoffmann-La Roche Ltd.
- 11.2.1.1. Overview
- 11.2.1.2. Products & Services
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. Financials (Based on Availability)
- 11.2.2. Abbott
- 11.2.2.1. Overview
- 11.2.2.2. Products & Services
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. Financials (Based on Availability)
- 11.2.3. EKF Diagnostics Holding plc
- 11.2.3.1. Overview
- 11.2.3.2. Products & Services
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. Financials (Based on Availability)
- 11.2.4. Cardinal Health, Inc.
- 11.2.4.1. Overview
- 11.2.4.2. Products & Services
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. Financials (Based on Availability)
- 11.2.5. Thermo Fisher Scientific Inc.
- 11.2.5.1. Overview
- 11.2.5.2. Products & Services
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. Financials (Based on Availability)
- 11.2.6. Quest Diagnostics Incorporated
- 11.2.6.1. Overview
- 11.2.6.2. Products & Services
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. Financials (Based on Availability)
- 11.2.7. BD
- 11.2.7.1. Overview
- 11.2.7.2. Products & Services
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. Financials (Based on Availability)
- 11.2.8. bioMérieux SA
- 11.2.8.1. Overview
- 11.2.8.2. Products & Services
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. Financials (Based on Availability)
- 11.2.9. Bio-Rad Laboratories Inc.
- 11.2.9.1. Overview
- 11.2.9.2. Products & Services
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Strategies
- 11.2.9.6. Financials (Based on Availability)
- 11.2.10. Trinity Biotech
- 11.2.10.1. Overview
- 11.2.10.2. Products & Services
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Strategies
- 11.2.10.6. Financials (Based on Availability)
- 11.2.11. QuidelOrtho Corporation
- 11.2.11.1. Overview
- 11.2.11.2. Products & Services
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Strategies
- 11.2.11.6. Financials (Based on Availability)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook